IBS Logo Primary.jpg
Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff
05 déc. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
Intelligent Fingerprinting Drug Screening System is expected to reduce P&O Ferries’ overall drug testing costs by 90% Easy-to-use, hygienic fingerprint sweat test improves the testing experience...
IBS Logo Primary.jpg
Leading Specialist Material Handling Company, Titan Cranes and Rigging Pty Ltd., Adopts Intelligent Fingerprinting Drug Screening System
30 nov. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBS Logo Primary.jpg
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023
29 nov. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBS Logo Primary.jpg
Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution
27 nov. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBS Logo Primary.jpg
Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
08 nov. 2023 16h21 HE | Intelligent Bio Solutions, Inc.
- First fiscal quarter revenue and government support income increased 191% year-over-year and 88% sequentially due to strong organic growth and execution of expansion plans - - Increased market...
IBS Logo Primary.jpg
Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand
24 oct. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
IBS Logo Primary.jpg
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
05 oct. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
VKVP Haulage adopts Fingerprint Drug Screening System to help drive proactive drug testing policy Auctus Management Group successfully completes 25,000 tests using the Company’s Intelligent...
IBS Logo Primary.jpg
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
04 oct. 2023 16h05 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions,...
IBS Logo Primary.jpg
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
02 oct. 2023 08h32 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions,...
IBS Logo Primary.jpg
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
27 sept. 2023 08h30 HE | Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...